Charles River Laboratories (CRL)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,596,880 | 2,976,290 | 2,534,820 | 2,114,600 | 1,634,580 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $3,596,880K)
= 0.00
Based on the data provided for Charles River Laboratories from 2019 to 2023, the debt-to-capital ratio has consistently remained at 0.00 over the past five years. This indicates that the company has not utilized any debt in its capital structure during this period. A debt-to-capital ratio of 0.00 suggests that the company has relied entirely on equity financing to support its operations and growth initiatives. This could signify a conservative financial strategy, as the absence of debt implies lower financial risk and potential interest expenses. However, it is essential to note that a zero debt-to-capital ratio may also limit the company's ability to leverage debt to potentially enhance returns on equity or take advantage of tax benefits associated with debt financing. Overall, the stability of the debt-to-capital ratio at 0.00 reflects Charles River Laboratories' consistent approach to maintaining a debt-free capital structure.
Peer comparison
Dec 31, 2023